All in one clinic to treat breast cancer. This is the objective that Clínica Diagonal in Barcelona has set itself in order to offer women suffering from this diagnosis comprehensive and professional care.
In this way, they were able to form a multidisciplinary team with the following specialties. Gynecology, oncology, plastic surgery, cosmetic surgery, radiology, nutrition, oncology nurse and oncology nurse assistant.
With the integration, they seek to achieve a better diagnosis for the benefit of the patient and to achieve a personalized treatment.
How the breast cancer treatment specialist team works
Clínica Diagonal begins the process by evaluating the situation of each case. In the first phase, the clinic’s Tumor Committee, composed of the specialties mentioned at the beginning, meets.
There they study and evaluate each patient in detail, so that no variable is overlooked and the diagnosis is very precise. They also permanently analyze the evolution indicators during each moment of the treatment.
In this way, each professional of the medical team shares the results obtained, as well as the results of the investigations that each one is carrying out in his or her area.
Thanks to the ongoing research carried out at the clinic in Barcelona, early detection of the disease and advances in treatment have been achieved, increasing the survival of patients.
The great advantage for each case is that the medical team can have a 360º view of the patient.
This type of management is very positive, since the team of professionals, each from their own discipline, determines the diagnosis, treatment and follow-up of the patient, since 1% of breast cancers are suffered by men.
Mango reopens store on Diagonal Avenue
Breast cancer in Spain
This type of cancer is the most common cancer among women and the most common cause of death worldwide.
In Spain in particular, 34,353 cases of breast cancer were diagnosed in 2021, according to the Observatory of the Spanish Association Against Cancer, AECC.
For its part, the World Health Organization (WHO) indicates that one in 12 women may develop this cancer during their lifetime. However, the WHO also indicates that the mortality rate of this type of patient has decreased by 40% over the last 40 years.
According to Dr. Saioa Gorostidi, gynecologist at Clínica Diagonal, currently the survival rate for this type of cancer can be 85%.
The important thing is to detect it from the beginning at stage 1, since the probability of survival is 90%. But if it is discovered when the tumor has spread causing metastasis, there is only a 15% to 20% chance of survival.
